Literature data confirm that in acromegaly, the most prevalent condition in our study group, GH and IGF-I contribute to the development of cardiovascular and metabolic complications through systemic inflammation, endothelial dysfunction, and insulin resistance (54). The gene discussed is GH1; the disease is endothelial dysfunction.